Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
93.03 (1y: +112%)
Market Cap 6.76 B P/E(ttm)
Enterprise Value 6.2 B P/B 8.20
ONXX- NAS (USA)
Onyx Pharmaceuticals, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$93.03
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,758Revenue $M436Net Margin (%)-51.9Z-Score7.8
Enterprise Value $M6,205EPS $-2.5Operating Margin %-73.7F-Score2
P/E(ttm))0Cash Flow Per Share $0.5Pre-tax Margin (%)-78.6Higher ROA y-yN
Price/Book8.210-y EBITDA Growth Rate %0Quick Ratio6.6Cash flow > EarningsN
Price/Sales14.35-y EBITDA Growth Rate %0Current Ratio5.9Lower Leverage y-yY
Price/Cash Flow156y-y EBITDA Growth Rate %-352.2ROA % (ttm)-13.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-22.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M72.0ROI % (ttm)-7.0Gross Margin Increase y-yN

Gurus Latest Trades with ONXX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.

No Entry found!
Total Records: 0

ONXX is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ONXX Vanguard Health Care Fund 2013-03-311,022,7001.420.36
Premium Most recent portfolio changes are included for Premium Members only!


ONXX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lasowski JuergenEVP, Corp. Dev & Strategy 2013-05-14Sell4,182$96.6-3.53view
Torley HelenEVP, Chief Commercial Officer 2013-05-13Sell8,250$98.13-5.03view
Fust Matthew KEVP & CFO 2013-05-13Sell10,269$98.22-5.12view
GODDARD PAULDirector 2013-05-08Sell1,000$95-1.91view
Foster-Cheek Kaye ISVP, Global Human Resources 2013-05-07Sell8,877$89.843.73view
SHEMA SUZANNE MEVP, GC and Corp. Secretary 2013-05-07Sell4,051$89.973.58view
WIGGANS THOMAS GDirector 2013-05-06Sell4,500$91.012.4view
GODDARD PAULDirector 2013-05-01Sell5,000$93.020.18view
GRILLO LOPEZ ANTONIO JDirector 2013-04-23Sell5,000$101.28-7.99view
Fust Matthew KEVP & CFO 2013-04-15Sell1,347$95.15-2.06view

Press Releases about ONXX:

Quarterly/Annual Reports about ONXX:

News about ONXX:

Articles On GuruFocus.com
Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
5 Inexpensive Stocks for Your Portfolio Jan 19 2012 
ONYX Pharmaceuticals Inc. (ONXX) EVP & COO Laura Brege sells 12,500 Shares Jan 20 2011 
ONYX Pharmaceuticals Inc. (ONXX) CFO Matthew K Fust sells 1,812 Shares Jan 07 2011 
ONYX Pharmaceuticals Inc. (ONXX) President & CEO N Anthony Coles sells 13,669 Shares Dec 08 2010 
ONYX Pharmaceuticals Inc. (ONXX) EVP & COO Laura Brege sells 25,000 Shares Nov 10 2010 
ONYX Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Edward Owens Buys Johnson & Johnson, Baxter International, Regeneron Pharmaceuticals Inc., Sells Iro Aug 19 2010 
ONYX Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2010 
ONYX Pharmaceuticals Inc. Reports Operating Results (10-Q) May 04 2010 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK